Telstar manages plant constructions for Square Pharmaceuticals

For the production of oral solids and parenterals

Telstar is building two plants for Square Pharmaceuticals

Telstar is managing the construction of two pharmaceutical plants for Square Pharmaceuticals, the largest manufacturer of pharmaceuticals in Bangladesh.

The first project will involve building a plant for the production of oral solids, which includes a four-storey building of 32,000m2 with 7 fluidised bed granulation lines, 11 tablet lines, 4 lines for capsules, and 16 primary and secondary packaging lines, plus a second service building of 1,000m2.

The second project consists of a 20,000m2 four-storey building for the production of parenterals in small and large volume formats, including two lines for manufacturing BFS bottles with two reactors of 20,000 litres each, a line for manufacturing glass bottles, one for bags, two for vials, two for preloaded syringes, one for lyophilised vials with two freeze-dryers and one topical aerosol production line.

Terrassa, Spain-based Telstar carried the engineering for both plants and handled project administration. Start-up and qualification is scheduled for the first half of next year.

Since 2003, Telstar has collaborated with Square Pharmaceuticals, headquartered in Dhaka, on a number of complex projects.

Examples include building Square’s cephalosporin plant in 2005, as well as a new plant for sterile filling and bottling of pharmaceutical liquids with Blow-Fill-Seal (BFS) technology in 2007, a new insulin production plant in 2010 (with the ability to produce up to 13 million vials of insulin per year) and an SVPO plant for production of small volume parenterals and ophthalmology products inaugurated in 2008 in Dhaka.

Companies